early breast cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) female patients aged 18-70 years; 2) early breast cancer patients with clinical cancer diameter of <2cm, no obvious axillary lymph node metastasis or surgery. Histopathological diagnosis was performed by air core needle biopsy before treatment; 3) the size of the tumor can be measured; 4) there was no other malignant tumor. Before treatment, abdominal ultrasound and chest X-ray were used to detect if there was distant metastasis; 5) ability to comply program; 6) the ECOG score must be 0 or 1; 7) the patient volunteered to participate in the study and signed the informed consent.
Exclusion criteria
Exclusion criteria: 1) the channel (puncture path) is unclear; 2) liver function, renal function impairment, severe heart failure; 3) combined with active infection; 4) there were abnormal coagulation dysfunction and obvious hemogram abnormalities, and there were obvious bleeding tendency; 5) patients who can not visit and review on time; 6) the patients who were considered unsuitable for the trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 5 year overall survival rate;5 year disease-free survival rate; | — |
Countries
China
Contacts
Southwest Hospital